Vanguard Group »

Mersana Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 6.7M 2.01
2024-03-31 $28M 6.3M 4.48
2023-12-31 $15M 6.2M 2.32
2023-09-30 $7.9M 6.2M 1.27
2023-06-30 $19M 5.7M 3.29
2023-03-31 $19M 4.6M 4.11
2022-12-31 $26M 4.4M 5.86
2022-06-30 $22M 4.7M 4.62
2022-03-31 $14M 3.4M 3.99
2021-09-30 $35M 3.7M 9.43
2021-06-30 $43M 3.2M 13.58
2021-03-31 $50M 3.1M 16.18
2020-12-31 $82M 3.1M 26.61
2020-09-30 $53M 2.8M 18.62
2020-06-30 $67M 2.9M 23.40
2020-03-31 $11M 1.9M 5.83
2019-12-31 $11M 1.9M 5.73
2019-09-30 $3.0M 1.9M 1.58
2019-03-31 $7.9M 1.5M 5.25
2018-12-31 $1.1M 267k 4.09
2018-09-30 $6.0M 601k 10.00
2018-06-30 $8.0M 447k 17.86
2018-03-31 $6.7M 422k 15.80
2017-12-31 $3.0M 181k 16.41
2017-09-30 $2.7M 158k 17.31
2017-06-30 $1.0M 75k 13.94